Interleukin-1B polymorphisms and gastric cancer risk - A meta-analysis
Interleukin-1B polymorphisms and gastric cancer risk - A meta-analysis
复制标题
DOI:
10.1158/1055-9965.epi-06-0267
复制
发表时间:
2006-10-01
影响因子:
3.8
通讯作者:
Rabkin, Charles S.
中科院分区:
文献类型:
--
作者:
Kamangar, Farin;Cheng, Cindy;Rabkin, Charles S.
Some studies have reported that proinflammatory polymorphisms in interleukin-1B (IL-1B) and IL-1 receptor antagonist (IL-1RN) genes are associated with increased gastric cancer risk. However, other studies have shown null or inverse associations. This meta-analysis reviews and summarizes published evidence for these associations. Searching the PubMed Database yielded 35 studies that reported on the association between IL-1B -511 C > T, IL-1B -31 T > C, or IL-1RN variable number tandem repeat polymorphisms and gastric cancer risk. Q-statistics and 12 statistics were calculated to examine heterogeneity. Summary odds ratios (OR) and 95% confidence intervals (95% CI) were calculated in the random-effects model using the DerSimonian-Laird method. For all gastric cancers, the overall ORs (95% CIs) for IL-1B -511 CT versus CC and TT versus CC genotypes were 1.07 (0.91-1.25) and 1.16 (0.95-1.42), respectively. ORs (95% CIs) for the association between IL-1B -31 CT versus TT and CC versus TT genotypes were 0.99 (0.83-1.19) and 0.98 (0.78-1.21), respectively. For the associations between IL-1RN and gastric cancer, ORs (95% CIs) for *2/L versus LL and *2/*2 versus L/L were 1.15 (0.96-1.38) and 1.23 (0.79-1.92). For each of the examined associations, there was significant heterogeneity among studies; P-heterogeneity